These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8510742)

  • 1. Stanford seeks life after Cohen-Boyer patent expires.
    Lehrman S
    Nature; 1993 Jun; 363(6430):574. PubMed ID: 8510742
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 3. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 5. Hatch-waxman changes debated.
    Chahine K
    Nat Biotechnol; 2000 Jul; 18(7):710-1. PubMed ID: 10888831
    [No Abstract]   [Full Text] [Related]  

  • 6. Affymetrix in new patents row.
    Ledford H
    Nature; 2008 Jul; 454(7203):377. PubMed ID: 18650873
    [No Abstract]   [Full Text] [Related]  

  • 7. A footnote to the Cohen-Boyer patent and other musings.
    Goldstein JA
    Recomb DNA Tech Bull; 1982 Dec; 5(4):180-8. PubMed ID: 6962469
    [No Abstract]   [Full Text] [Related]  

  • 8. Will publication of patent applications really affect biotechnology?
    Tsevdos EJ; Toffenetti JL; Lisa Wilson M
    Nat Biotechnol; 2000 Jul; 18(7):795-6. PubMed ID: 10888853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 10. International patent filing. Factors to consider in deciding when and where to file outside the United States.
    Agris CH
    Nat Biotechnol; 1998 May; 16(5):479-80. PubMed ID: 9592399
    [No Abstract]   [Full Text] [Related]  

  • 11. US to rule on research patent.
    Ruttimann J
    Nature; 2006 Mar; 440(7084):587. PubMed ID: 16572133
    [No Abstract]   [Full Text] [Related]  

  • 12. Making dollars out of DNA. The first major patent in biotechnology and the commercialization of molecular biology, 1974-1980.
    Hughes SS
    Isis; 2001 Sep; 92(3):541-75. PubMed ID: 11810894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotechnology: Cohen-Boyer patent finally confirmed.
    Beardsley T
    Nature; 1984 Sep 6-11; 311(5981):3. PubMed ID: 6590968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intellectual property. Depth charges aimed at Columbia's 'submarine patent'.
    Marshall E
    Science; 2003 Jul; 301(5632):448. PubMed ID: 12881539
    [No Abstract]   [Full Text] [Related]  

  • 15. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 16. U.S. intellectual property law. Government questions sequencing patent.
    Kintisch E
    Science; 2006 Nov; 314(5803):1230. PubMed ID: 17124298
    [No Abstract]   [Full Text] [Related]  

  • 17. Business: stepping out.
    Dalton R
    Nature; 2008 Mar; 452(7184):146. PubMed ID: 18337794
    [No Abstract]   [Full Text] [Related]  

  • 18. Europe's patent rebellion.
    Wadman M
    Fortune; 2001 Oct; 144(6):44. PubMed ID: 11586878
    [No Abstract]   [Full Text] [Related]  

  • 19. The technology trap.
    Gewin V
    Nature; 2005 Oct; 437(7061):948-9. PubMed ID: 16222269
    [No Abstract]   [Full Text] [Related]  

  • 20. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.